FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385778852> ?p ?o ?g. }

• W4385778852 endingPage "e068865" @default.
• W4385778852 startingPage "e068865" @default.
• W4385778852 abstract "COMMANDER-HF was a randomised trial comparing rivaroxaban 2.5 mg two times a day to placebo, in addition to antiplatelet therapy, in patients hospitalised for worsening heart failure with coronary artery disease and sinus rhythm. Patients with diabetes are at increased risk of cardiovascular events and therefore have more to gain.In this post-hoc analysis, we evaluated the efficacy and safety of rivaroxaban in patients with (n=2052) and without diabetes (n=2970). The primary outcome was the composite of cardiovascular death, myocardial infarction (MI) or ischaemic stroke. HRs and 95% CIs with interaction analyses were used to describe event-rates and treatment effects. Patients with diabetes had a higher prevalence of cardiovascular comorbidities (eg, hypertension, obesity) and increased incidence of cardiovascular events. Adjusted HRs for events in people with versus without diabetes were 1.34 (95% CI 1.19 to 1.50) for the primary outcome, 1.21 (95% CI 0.84 to 1.75) for stroke, 1.51 (95% CI 1.14 to 1.99) for MI, 1.17 (95% CI 1.05 to 1.31) for heart failure hospitalisation and 1.06 (95% CI 0.56 to 2.01) for major bleeding. Rivaroxaban had no significant effect on event-rates in patients with and without diabetes (all interaction p values >0.05). Low-dose rivaroxaban was associated with an overall reduction in ischaemic stroke (HR 0.66; 95% CI 0.47 to 0.95), with no apparent subgroup interaction according to diabetes status (p-int=0.93).In COMMANDER-HF a diagnosis of diabetes conferred higher rates of cardiovascular events that, with exception of ischaemic stroke, was not substantially reduced by rivaroxaban. Rivaroxaban was associated with reduced risk of ischaemic stroke for patients with and without diabetes.NCT01877915; Post-results." @default.
• W4385778852 created "2023-08-13" @default.
• W4385778852 creator A5001704230 @default.
• W4385778852 creator A5002026128 @default.
• W4385778852 creator A5016901394 @default.
• W4385778852 creator A5017160240 @default.
• W4385778852 creator A5020254504 @default.
• W4385778852 creator A5036821495 @default.
• W4385778852 creator A5054496507 @default.
• W4385778852 creator A5056960938 @default.
• W4385778852 creator A5064906147 @default.
• W4385778852 creator A5067422552 @default.
• W4385778852 creator A5069496306 @default.
• W4385778852 creator A5082032866 @default.
• W4385778852 date "2023-08-01" @default.
• W4385778852 modified "2023-10-18" @default.
• W4385778852 title "Cardiovascular effects of rivaroxaban in heart failure patients with sinus rhythm and coronary disease with and without diabetes: a retrospective international cohort study from COMMANDER-HF" @default.
• W4385778852 cites W1604096140 @default.
• W4385778852 cites W1606378021 @default.
• W4385778852 cites W1945494843 @default.
• W4385778852 cites W1975689592 @default.
• W4385778852 cites W2004365704 @default.
• W4385778852 cites W2108321760 @default.
• W4385778852 cites W2117677020 @default.
• W4385778852 cites W2135378280 @default.
• W4385778852 cites W2746087247 @default.
• W4385778852 cites W2749380187 @default.
• W4385778852 cites W2888292644 @default.
• W4385778852 cites W2891200806 @default.
• W4385778852 cites W2892792070 @default.
• W4385778852 cites W2940672413 @default.
• W4385778852 cites W2954412861 @default.
• W4385778852 cites W2955031471 @default.
• W4385778852 cites W2968633786 @default.
• W4385778852 cites W3004095885 @default.
• W4385778852 cites W3013428853 @default.
• W4385778852 cites W3013682615 @default.
• W4385778852 cites W3210840363 @default.
• W4385778852 cites W4205813010 @default.
• W4385778852 cites W4229831650 @default.
• W4385778852 cites W4243656112 @default.
• W4385778852 doi "https://doi.org/10.1136/bmjopen-2022-068865" @default.
• W4385778852 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37567750" @default.
• W4385778852 hasPublicationYear "2023" @default.
• W4385778852 type Work @default.
• W4385778852 citedByCount "0" @default.
• W4385778852 crossrefType "journal-article" @default.
• W4385778852 hasAuthorship W4385778852A5001704230 @default.
• W4385778852 hasAuthorship W4385778852A5002026128 @default.
• W4385778852 hasAuthorship W4385778852A5016901394 @default.
• W4385778852 hasAuthorship W4385778852A5017160240 @default.
• W4385778852 hasAuthorship W4385778852A5020254504 @default.
• W4385778852 hasAuthorship W4385778852A5036821495 @default.
• W4385778852 hasAuthorship W4385778852A5054496507 @default.
• W4385778852 hasAuthorship W4385778852A5056960938 @default.
• W4385778852 hasAuthorship W4385778852A5064906147 @default.
• W4385778852 hasAuthorship W4385778852A5067422552 @default.
• W4385778852 hasAuthorship W4385778852A5069496306 @default.
• W4385778852 hasAuthorship W4385778852A5082032866 @default.
• W4385778852 hasBestOaLocation W43857788521 @default.
• W4385778852 hasConcept C126322002 @default.
• W4385778852 hasConcept C127413603 @default.
• W4385778852 hasConcept C134018914 @default.
• W4385778852 hasConcept C164705383 @default.
• W4385778852 hasConcept C2775914520 @default.
• W4385778852 hasConcept C2776301958 @default.
• W4385778852 hasConcept C2777180221 @default.
• W4385778852 hasConcept C2778198053 @default.
• W4385778852 hasConcept C2778213512 @default.
• W4385778852 hasConcept C2778661090 @default.
• W4385778852 hasConcept C2779161974 @default.
• W4385778852 hasConcept C2780645631 @default.
• W4385778852 hasConcept C500558357 @default.
• W4385778852 hasConcept C555293320 @default.
• W4385778852 hasConcept C71924100 @default.
• W4385778852 hasConcept C78519656 @default.
• W4385778852 hasConceptScore W4385778852C126322002 @default.
• W4385778852 hasConceptScore W4385778852C127413603 @default.
• W4385778852 hasConceptScore W4385778852C134018914 @default.
• W4385778852 hasConceptScore W4385778852C164705383 @default.
• W4385778852 hasConceptScore W4385778852C2775914520 @default.
• W4385778852 hasConceptScore W4385778852C2776301958 @default.
• W4385778852 hasConceptScore W4385778852C2777180221 @default.
• W4385778852 hasConceptScore W4385778852C2778198053 @default.
• W4385778852 hasConceptScore W4385778852C2778213512 @default.
• W4385778852 hasConceptScore W4385778852C2778661090 @default.
• W4385778852 hasConceptScore W4385778852C2779161974 @default.
• W4385778852 hasConceptScore W4385778852C2780645631 @default.
• W4385778852 hasConceptScore W4385778852C500558357 @default.
• W4385778852 hasConceptScore W4385778852C555293320 @default.
• W4385778852 hasConceptScore W4385778852C71924100 @default.
• W4385778852 hasConceptScore W4385778852C78519656 @default.
• W4385778852 hasIssue "8" @default.
• W4385778852 hasLocation W43857788521 @default.
• W4385778852 hasLocation W43857788522 @default.
• W4385778852 hasOpenAccess W4385778852 @default.
• W4385778852 hasPrimaryLocation W43857788521 @default.
• W4385778852 hasRelatedWork W1864361583 @default.

• next